BACKGROUND: Pregnancy-associated malaria (PAM) produces poor birth outcomes, but its prevalence is commonly estimated in convenience samples. METHODS: We assessed the prevalence of malaria using real-time polymerase chain reaction (PCR) and estimated the consequences of infection on birth outcomes, using specimens from a nationally representative sample of 4570 women of childbearing age (WOCBA) responding to the 2007 Demographic and Health Survey in Democratic Republic of the Congo (DRC). RESULTS: Overall, 31.2% (95% confidence interval [CI], 29.2-33.1) of WOCBA were parasitemic, which was significantly more common in pregnant (37.2% [31.0-43.5]) than nonpregnant women (30.4% [CI, 28.4-32.5], prevalence ratio [PR] 1.22 [1.02-1.47]). Plasmodium falciparum was highest among pregnant women (36.6% vs 28.8%, PR 1.27 [1.05-1.53]). By contrast, P malariae was less common in pregnant (0.6%) compared with nonpregnant women (2.7%, PR 0.23 [0.09-0.56]). Extrapolation of the prevalence estimate to the population at risk of malaria in DRC suggests 1.015 million births are affected by P falciparum infection annually, and that adherence to preventive measures could prevent up to 549 000 episodes of pregnancy-associated malaria and 47 000 low-birth-weight births. CONCLUSIONS: Pregnancy-associated malaria and its consequences are highly prevalent in the DRC. Increasing the uptake of malaria preventive measures represents a significant opportunity to improve birth outcomes and neonatal health.
BACKGROUND: Pregnancy-associated malaria (PAM) produces poor birth outcomes, but its prevalence is commonly estimated in convenience samples. METHODS: We assessed the prevalence of malaria using real-time polymerase chain reaction (PCR) and estimated the consequences of infection on birth outcomes, using specimens from a nationally representative sample of 4570 women of childbearing age (WOCBA) responding to the 2007 Demographic and Health Survey in Democratic Republic of the Congo (DRC). RESULTS: Overall, 31.2% (95% confidence interval [CI], 29.2-33.1) of WOCBA were parasitemic, which was significantly more common in pregnant (37.2% [31.0-43.5]) than nonpregnant women (30.4% [CI, 28.4-32.5], prevalence ratio [PR] 1.22 [1.02-1.47]). Plasmodium falciparum was highest among pregnant women (36.6% vs 28.8%, PR 1.27 [1.05-1.53]). By contrast, P malariae was less common in pregnant (0.6%) compared with nonpregnant women (2.7%, PR 0.23 [0.09-0.56]). Extrapolation of the prevalence estimate to the population at risk of malaria in DRC suggests 1.015 million births are affected by P falciparum infection annually, and that adherence to preventive measures could prevent up to 549 000 episodes of pregnancy-associated malaria and 47 000 low-birth-weight births. CONCLUSIONS: Pregnancy-associated malaria and its consequences are highly prevalent in the DRC. Increasing the uptake of malaria preventive measures represents a significant opportunity to improve birth outcomes and neonatal health.
Authors: F P Mockenhaupt; B Rong; H Till; T A Eggelte; S Beck; C Gyasi-Sarpong; W N Thompson; U Bienzle Journal: Trop Med Int Health Date: 2000-03 Impact factor: 2.622
Authors: Stephanie Dellicour; Andrew J Tatem; Carlos A Guerra; Robert W Snow; Feiko O ter Kuile Journal: PLoS Med Date: 2010-01-26 Impact factor: 11.069
Authors: Anne-Maria Rantala; Steve M Taylor; Paul A Trottman; Mari Luntamo; Bernard Mbewe; Kenneth Maleta; Teija Kulmala; Per Ashorn; Steven R Meshnick Journal: Malar J Date: 2010-10-06 Impact factor: 2.979
Authors: Sylvia I Becker-Dreps; Andrea K Biddle; Audrey Pettifor; Gertrude Musuamba; David Nku Imbie; Steven Meshnick; Frieda Behets Journal: Am J Trop Med Hyg Date: 2009-09 Impact factor: 2.345
Authors: Carlos A Guerra; Priscilla W Gikandi; Andrew J Tatem; Abdisalan M Noor; Dave L Smith; Simon I Hay; Robert W Snow Journal: PLoS Med Date: 2008-02 Impact factor: 11.069
Authors: Andreea Waltmann; Jaymin C Patel; Kyaw L Thwai; Nicholas J Hathaway; Christian M Parobek; Achille Massougbodji; Nadine Fievet; Jeffery A Bailey; Philippe Deloron; Jonathan J Juliano; Nicaise Tuikue Ndam; Steven R Meshnick Journal: Am J Trop Med Hyg Date: 2018-01 Impact factor: 2.345
Authors: Jaymin C Patel; Steve M Taylor; Patricia C Juliao; Christian M Parobek; Mark Janko; Luis Demetrio Gonzalez; Lucia Ortiz; Norma Padilla; Antoinette K Tshefu; Michael Emch; Venkatachalam Udhayakumar; Kim Lindblade; Steven R Meshnick Journal: Emerg Infect Dis Date: 2014-06 Impact factor: 6.883
Authors: Hélène M De Nys; Sébastien Calvignac-Spencer; Christophe Boesch; Pierre Dorny; Roman M Wittig; Roger Mundry; Fabian H Leendertz Journal: Malar J Date: 2014-10-20 Impact factor: 2.979
Authors: Melchior Kashamuka Mwandagalirwa; Lauren Levitz; Kyaw L Thwai; Jonathan B Parr; Varun Goel; Mark Janko; Antoinette Tshefu; Michael Emch; Steven R Meshnick; Margaret Carrel Journal: Malar J Date: 2017-11-09 Impact factor: 2.979
Authors: Steve M Taylor; Alejandro L Antonia; Christian M Parobek; Jonathan J Juliano; Mark Janko; Michael Emch; Md Tauqeer Alam; Venkatachalam Udhayakumar; Antoinette K Tshefu; Steven R Meshnick Journal: Sci Rep Date: 2013-01-30 Impact factor: 4.379
Authors: Jenny Hill; Jenna Hoyt; Anna Maria van Eijk; Feiko O ter Kuile; Jayne Webster; Richard W Steketee Journal: PLoS Med Date: 2014-09-09 Impact factor: 11.069